Výsledky vyhledávání - "Sai Krishna Susarla"

Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study

Autor: BC Rajashakar, Supriya Barsode, Devi Prasad Sahoo, Sonali Palkar, Pardha Saradhi Sv, G. Sandhya, Rajendra Lingala, Arundhati Diwan, Sai Krishna Susarla, M. Satish

Publikováno v: Vaccine. 39(15)

Background Hepatitis-A is an acute viral infection of the liver. Hepatitis-A virus has worldwide spread and is endemic in India. Though the disease is self-limiting in most cases, outbreaks are reported frequently from both developing and developed c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd0246bebab61684d2fc6d27ea4be94
https://pubmed.ncbi.nlm.nih.gov/33741190

Zobrazit plný text záznamu

Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study

Autor: Saji James, M. Satish, Mandyam Dhati Ravi, Ramchandra Dhongade, Sheila Bhave, T Ramesh Babu, Rajat Kumar Das, B. Krishnamurthy, Rajib Kumar Ray, Mukta Mantan, Sai Krishna Susarla, G. Sandhya, Madhu Gupta, Devi Prasad Sahoo

Publikováno v: Vaccine. 37(36)

Background A liquid Pentavalent (DTwP-Hb-Hib) combination vaccine, developed by Human Biologicals Institute, underwent a Phase III clinical study in India. In this randomized, single blind, non-inferiority study, the immunogenicity and safety of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::592a283e82e6bf9a8dd30184b165b15f
https://pubmed.ncbi.nlm.nih.gov/31331773

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání